S.C. Centrul Medical Medicum SRL

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Crohn's disease1 trial
• Ulcerative colitis1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Eli Lilly and Company2 trials

Running trials

• Active, not recruiting

  A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  NCT06598943· Phase 2· Eli Lilly and Company· Source

• Active, not recruiting

  A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

  NCT04232553· Phase 3· Eli Lilly and Company· Source